Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3376 - 3400 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR02
  • Cytolipin R(d18:1/18:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261573 1254.781243 C62H114N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR01
  • Cytolipin R(d18:1/16:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261572 1226.749943 C60H110N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ08
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Isoglobotriglycosylceramide(d18:1/26:1(17Z))
44261571 1161.811419 C62H115NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ07
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Isoglobotriglycosylceramide(d18:1/24:1(15Z))
44261570 1133.780119 C60H111NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ06
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Isoglobotriglycosylceramide(d18:1/26:0)
44261569 73269 1163.827069 C62H117NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ05
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Isoglobotriglycosylceramide(d18:1/24:0)
44261568 52616 1135.795769 C60H113NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ04
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Isoglobotriglycosylceramide(d18:1/22:0)
44261567 1107.764469 C58H109NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ03
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Isoglobotriglycosylceramide(d18:1/20:0)
44261566 1079.733169 C56H105NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ02
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Isoglobotriglycosylceramide(d18:1/18:0)
44261565 1051.701869 C54H101NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ01
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Isoglobotriglycosylceramide(d18:1/16:0)
44261564 1023.670569 C52H97NO18
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261563 1819.059438 C88H158N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261562 1791.028138 C86H154N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261561 1821.075088 C88H160N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261560 1793.043788 C86H156N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261559 1765.012488 C84H152N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261558 1736.981188 C82H148N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261557 1708.949888 C80H144N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261556 1680.918588 C78H140N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV08
  • Gala 1-3Lex(d18:1/26:1(17Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261555 1673.001528 C82H148N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV07
  • Gala 1-3Lex(d18:1/24:1(15Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261554 1644.970228 C80H144N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV06
  • Gala 1-3Lex(d18:1/26:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261553 1675.017178 C82H150N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV05
  • Gala 1-3Lex(d18:1/24:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261552 1646.985878 C80H146N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV04
  • Gala 1-3Lex(d18:1/22:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261551 1618.954578 C78H142N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV03
  • Gala 1-3Lex(d18:1/20:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261550 1590.923278 C76H138N2O32

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024